Log in to save to my catalogue

Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate C...

Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate C...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_7298660

Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy

About this item

Full title

Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy

Publisher

Korea (South): Korean Society for Sexual Medicine and Andrology

Journal title

The World Journal of Men's Health, 2020, 38(2), , pp.226-235

Language

English

Formats

Publication information

Publisher

Korea (South): Korean Society for Sexual Medicine and Andrology

More information

Scope and Contents

Contents

The purpose of this study was to determine the comparative effectiveness of androgen deprivation therapy (ADT) combined with docetaxel (DTX)-based chemotherapy in Korean and Japanese castration-resistant prostate cancer (CRPC) patient cohorts.
Metastatic CRPC patients who underwent more than three DTX-based chemotherapy cycles in Korea and Japan...

Alternative Titles

Full title

Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_7298660

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_7298660

Other Identifiers

ISSN

2287-4208

E-ISSN

2287-4690

DOI

10.5534/wjmh.190029

How to access this item